Enochian Biosciences, Inc.
ENOB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | $0 | -$0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.13 | -0.76 | 0.001 | -0.04 |
| % Growth | 117.1% | -63,433.3% | 103% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$30 | $30 | $0 |
| Free Cash Flow | -$0 | -$30 | $11,804 | -$0 |